139 related articles for article (PubMed ID: 38320756)
81. Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19.
Ingul CB; Edvardsen A; Follestad T; Trebinjac D; Ankerstjerne OAW; Brønstad E; Rasch-Halvorsen Ø; Aarli B; Dalen H; Nes BM; Lerum TV; Einvik G; Stavem K; Skjørten I
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36137587
[TBL] [Abstract][Full Text] [Related]
82. Exercise impedance cardiography reveals impaired hemodynamic responses to exercise in hypertensives with dyspnea.
Kurpaska M; Krzesiński P; Gielerak G; Uziębło-Życzkowska B; Banak M; Stańczyk A; Piotrowicz K
Hypertens Res; 2019 Feb; 42(2):211-222. PubMed ID: 30504821
[TBL] [Abstract][Full Text] [Related]
83. [Exercise capacity in patients with pulmonary sarcoidosis].
Błaut-Jurkowska J; Knap K; Kaźnica-Wiatr M; Żygadło A; Tomkiewicz-Pająk L; Podolec P; Olszowska M
Pol Merkur Lekarski; 2017 Aug; 43(254):61-65. PubMed ID: 28875971
[TBL] [Abstract][Full Text] [Related]
84. Role of the cardio-pulmonary exercise test and six-minute walking test in the evaluation of exercise performance in patients with late-onset Pompe disease.
Crescimanno G; Modica R; Lo Mauro R; Musumeci O; Toscano A; Marrone O
Neuromuscul Disord; 2015 Jul; 25(7):542-7. PubMed ID: 25908581
[TBL] [Abstract][Full Text] [Related]
85. Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease.
Wu CW; Hsieh PC; Yang MC; Tzeng IS; Wu YK; Lan CC
Int J Chron Obstruct Pulmon Dis; 2019; 14():2543-2551. PubMed ID: 31819392
[TBL] [Abstract][Full Text] [Related]
86. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy.
Flaherty KR; Wald J; Weisman IM; Zeballos RJ; Schork MA; Blaivas M; Rubenfire M; Martinez FJ
Am J Respir Crit Care Med; 2001 Aug; 164(3):425-32. PubMed ID: 11500344
[TBL] [Abstract][Full Text] [Related]
87. Protracted respiratory findings in children post-SARS-CoV-2 infection.
Leftin Dobkin SC; Collaco JM; McGrath-Morrow SA
Pediatr Pulmonol; 2021 Dec; 56(12):3682-3687. PubMed ID: 34534416
[TBL] [Abstract][Full Text] [Related]
88. Determinants of exercise capacity in obese and non-obese COPD patients.
Rodríguez DA; Garcia-Aymerich J; Valera JL; Sauleda J; Togores B; Galdiz JB; Gea J; Orozco-Levi M; Ferrer A; Gomez FP; Barberà JA; Serra I; Antó JM; Roca J;
Respir Med; 2014 May; 108(5):745-51. PubMed ID: 24565602
[TBL] [Abstract][Full Text] [Related]
89. Investigation of dyspnea using cardiopulmonary exercise test among patients resorting to the respiratory tests.
Kiaee SZF; Rahimi B
Eur J Transl Myol; 2018 Jul; 28(3):7556. PubMed ID: 30344976
[TBL] [Abstract][Full Text] [Related]
90. Bilevel exercise training and directed breathing relieves exertional dyspnea for male smokers.
Gimenez M; Saavedra P; Martin N; Polu JM; López D; Gómez A; Servera E
Am J Phys Med Rehabil; 2012 Oct; 91(10):836-45. PubMed ID: 22760109
[TBL] [Abstract][Full Text] [Related]
91. Cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease.
Ong KC; Ong YY
Ann Acad Med Singap; 2000 Sep; 29(5):648-52. PubMed ID: 11126703
[TBL] [Abstract][Full Text] [Related]
92. Exercise testing in survivors of intensive care--is there a role for cardiopulmonary exercise testing?
Benington S; McWilliams D; Eddleston J; Atkinson D
J Crit Care; 2012 Feb; 27(1):89-94. PubMed ID: 21958985
[TBL] [Abstract][Full Text] [Related]
93. Correlation Between Cardiopulmonary Exercise Test, Spirometry, and Congenital Heart Disease Severity in Pediatric Population.
Morales Mestre N; Reychler G; Goubau C; Moniotte S
Pediatr Cardiol; 2019 Apr; 40(4):871-877. PubMed ID: 30850878
[TBL] [Abstract][Full Text] [Related]
94. Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection.
Palacios S; Krivchenia K; Eisner M; Young B; Ramilo O; Mejias A; Lee S; Kopp BT
Pediatr Pulmonol; 2022 Oct; 57(10):2455-2463. PubMed ID: 35775163
[TBL] [Abstract][Full Text] [Related]
95. An evaluation of integrated cardiopulmonary exercise testing in a pulmonary function laboratory.
Sridhar MK; Carter R; Banham SW; Moran F
Scott Med J; 1995 Aug; 40(4):113-6. PubMed ID: 8787110
[TBL] [Abstract][Full Text] [Related]
96. Performance and Interpretation of Invasive Hemodynamic Exercise Testing.
Jain CC; Borlaug BA
Chest; 2020 Nov; 158(5):2119-2129. PubMed ID: 32473950
[TBL] [Abstract][Full Text] [Related]
97. Multivariate Criteria Most Accurately Distinguish Cardiac from Noncardiac Causes of Dyspnea.
Ahmad MN; Yusuf SH; Ullah R; Ahmad MM; Ellis MK; Yousaf H; Paterick TE; Ammar KA
Tex Heart Inst J; 2015 Dec; 42(6):514-21. PubMed ID: 26664302
[TBL] [Abstract][Full Text] [Related]
98. Mechanism for temporal changes in exercise capacity after Fontan palliation: Role of Doppler echocardiography.
Egbe A; Khan AR; Miranda WR; Ammash NM; Warnes CA; Said SS; Taggart NW; Akintoye E; Veldtman GR; Connolly HM
Am Heart J; 2018 Feb; 196():144-152. PubMed ID: 29421006
[TBL] [Abstract][Full Text] [Related]
99. Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency.
Gille T; Laveneziana P
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34853093
[TBL] [Abstract][Full Text] [Related]
100. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis.
de Boer S; Kolbe J; Wilsher ML
Respirology; 2014 May; 19(4):604-7. PubMed ID: 24666931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
